Quality, Technological Innovation and Research
Phytomedics technologies assure consistent, safe and cost-effective production of commercial quantities of botanical drugs, thus overcoming major hurdles hampering the development of plant-derived health products. The R & D staff is comprised of 25 scientists, mostly Ph.D.'s, from eleven countries working in state-of-the-art facilities led by world-class researchers with industrial experience. Phytomedics aggressively pursues intellectual property protection. Currently, its patent portfolio includes 21 issued, and 22 filed pending issuance, that protect key products and technologies.